Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
36,42 USD | +1,62% | +4,54% | +18,32% |
11/04 | Collegium Pharmaceutical gaat $26,35 miljoen aan senior obligaties terugbetalen | MT |
26/02 | COLLEGIUM PHARMACEUTICAL, INC. : Piper Sandler herhaalt koopadvies | ZM |
Omzet 2024 * | 584 mln. 546 mln. | Omzet 2025 * | 596 mln. 557 mln. | Marktkapitalisatie | 1,19 mld. 1,11 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 116 mln. 108 mln. | Nettowinst (verlies) 2025 * | 144 mln. 135 mln. | EV/omzet 2024 * | 2,33 x |
Nettoschuld 2024 * | 167 mln. 156 mln. | Nettoliquiditeiten 2025 * | 42,16 mln. 39,43 mln. | EV/omzet 2025 * | 1,93 x |
K/w-verhouding 2024 * |
12,3
x | K/w-verhouding 2025 * |
9,92
x | Werknemers | 197 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 82,62% |
Recentste transcriptie over Collegium Pharmaceutical, Inc.
1 dag | +1,62% | ||
1 week | +4,54% | ||
Lopende maand | -6,18% | ||
1 maand | -8,79% | ||
3 maanden | +9,76% | ||
6 maanden | +66,30% | ||
Lopend jaar | +18,32% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Founder | 59 | 01-01-02 | |
Joseph Ciaffoni
CEO | Chief Executive Officer | 53 | 31-05-17 |
Colleen Tupper
DFI | Director of Finance/CFO | 48 | 24-05-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Garen Bohlin
BRD | Director/Board Member | 76 | 01-01-15 |
Gino Santini
BRD | Director/Board Member | 66 | 24-07-12 |
John Freund
BRD | Director/Board Member | 70 | 01-02-14 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.25% | 29 M€ | -4,33% |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 36,42 | +1,62% | 252 821 |
25-04-24 | 35,84 | +1,01% | 338 007 |
24-04-24 | 35,48 | -1,28% | 302 816 |
23-04-24 | 35,94 | +3,45% | 618 659 |
22-04-24 | 34,74 | -0,29% | 414 728 |
uitgestelde koers Nasdaq, 26 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+18,32% | 1,19 mld. | |
+25,83% | 661 mld. | |
+27,00% | 566 mld. | |
-6,76% | 352 mld. | |
+20,34% | 332 mld. | |
+3,00% | 283 mld. | |
+13,09% | 231 mld. | |
+5,46% | 200 mld. | |
-9,61% | 195 mld. | |
-6,26% | 145 mld. |